Guru Sonpavde, MD
Genitourinary Oncology Division, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA
Dr. Guru P. Sonpavde is the Bladder Cancer Director at the Dana Farber Cancer Institute. At Dana-Farber, he leads multiple cutting-edge clinical trials studying novel immunotherapy and targeted drugs clinical trials of bladder cancer patients. Additionally, he is on the steering committees of several major clinical trials attempting to improve outcomes and change the standard of care of bladder cancer patients. He completed his medical oncology fellowship at Indiana University. His primary focus is clinical trials to develop new drugs and combinations to treat urologic cancers with a focus on bladder cancer. He has also led translational projects and developed prognostic classifications and clinical endpoints focused on bladder cancer. He is a member of Southwest Oncology Group (SWOG) and Bladder Cancer Task Force of the U.S. NCI GU Steering Committee.